The state of New York has made the decision to update its medical marijuana eligibility rules and subsequently developed a new patient registration and cannabis certification system.
The new medical marijuana eligibility rules make the process more inclusive by allowing practitioners to give medical marijuana certifications for any condition that they say cannabis can help. In addition to this, additional practitioners, specifically midwives, podiatrists, and dentists, have been added to the list of practitioners that are allowed to issue medical marijuana certifications.
Doctors in New York can now prescribe pot for any ailment they see fit.
— New York Daily News (@NYDailyNews) January 25, 2022
The state launched a new certification and registration system for New York’s medical marijuana program, expanding patient access and eligibility.https://t.co/f0uqcNiIZc
Due to the previous rules which only allowed for patients with conditions such as cancer and epilepsy to be granted medical marijuana certifications, the updated eligibility standards will drastically increase public access to medicinal cannabis, a move that New York dispensaries are calling a common-sense advancement. “Yesterday’s decision to allow doctors to recommend medical marijuana to patients for any condition they see fit is a common-sense advancement that will help the program reach countless new patients,” says Vireo Health
State officials have said that the new registration and cannabis portals will issue certifications from the state ran Office Of Cannabis Management (OCM). Additionally, the OCM announced that it has waived patient registration fees, increased the supply limit from 30 days to 60 days, is now allowing the sale of whole flower cannabis products, and will accelerate the approval process for schools, residential facilities, and hospitals to have the ability to retain and administer cannabis products for patients.
If you are a current New York patient, state officials have said that previous certifications that were granted through the State Department of Health are valid until their respective expiration dates.
Overall, this is a great move by the state of New York and the team here at Commerce Puzzle fully expects that the increased access to medical cannabis will have a big impact on growing the New York cannabis economy.
According to a recent report released by the Marijuana Policy Project, state-legalized adult cannabis sales generated more than $3.7 billion in tax revenue across the United States in 2021.
As a consumer, it is no secret that the cost of purchasing goods and services has been on the rise across America. Considering the current state of the economy, some may be shocked to learn what impact this is, or potentially is not, having on consumers and business owners in the cannabis industry.
BioHarvest, an Israel-based health-tech company that has pledged to “marry science & technology with the power of nature,” is nearing the release of its first lab-grown cannabis product.
Subscribe to the Commerce Puzzle Cannabis Outlet for updates and free tools for growing your business in the cannabis industry.
We use cookies to ensure you get the best experience on our website. By continuing to browse on this website, you accept the use of cookies for traffic analysis, advertising, and service delivery.